Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases
- 14 January 2004
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 25 (3) , 211-214
Abstract
We aimed to investigate the efficacy and safety profile of high-dose intravenous immunoglobulin (HD-IVIG) therapy in patients with severe systemic lupus erythematosus (SLE), inflammatory muscle disease (IMD), Wegener’s granulomatosis (WG), and/or concurrent infection who failed to respond to standard therapies. We evaluated the records of eight patients with SLE, eight with IMD, and four with WG who were treated with HD-IVIG (2 g/kg per month for 1–12 months) for active disease in 19 patients and concurrent infection in three (mycobacterial in two with SLE and cytomegaloviral in one with WG). Systemic lupus erythematosus disease activity index (SLEDAI) scores before and after HD-IVIG were statistically analysed. Remission was achieved in 14 cases (70%). The SLEDAI scores significantly decreased in patients with SLE (P=0.02). No serious side effect was observed. High-dose IVIG may be used as an adjunctive treatment in connective tissue diseases that do not respond to standard therapies or as alternative treatment for patients with concurrent severe infections or for whom immunosuppressives are contraindicated.Keywords
This publication has 33 references indexed in Scilit:
- A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancyAmerican Journal of Obstetrics and Gynecology, 2000
- Successful treatment of early secondary myelofibrosis in SLE with IVIGLupus, 1997
- Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosusArthritis & Rheumatism, 1997
- Juvenile dermatomyositis: treatment with intravenous gammaglobulinBritish Journal of Dermatology, 1994
- Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulinJournal of Allergy and Clinical Immunology, 1991
- The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosisArthritis & Rheumatism, 1990
- Intravenous immunoglobulin therapy in systemic lupus erythematosus‐associated thrombocytopeniaArthritis & Rheumatism, 1990
- LUPUS ANTICOAGULANT AND RECURRENT FETAL LOSS: SUCCESSFUL TREATMENT WITH GAMMAGLOBULINThe Lancet, 1988
- INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1985
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982